History
  • No items yet
midpage
754 F. Supp. 2d 527
E.D.N.Y
2010
Read the full case

Background

  • Enzymotec sued NBTY for breach of agreements, misrepresentation as to exclusivity, and Lanham Act false advertising.
  • Three motions were pending: Enzymotec to amend the complaint for Breach of Supply Agreement, NBTY for partial summary judgment dismissing Lanham Act claim, and Enzymotec for a sur-reply (denied as moot).
  • The February 2006 Agreement allegedly bound NBTY to exclusively purchase PS-20 from Enzymotec; Lipogen’s PS-20 issues and subsequent renewals are disputed.
  • Enzymotec alleged that, based on representations through 2006–2008, NBTY treated Enzymotec as its exclusive PS-20 supplier and even funded advertising and clinical trials for Neuro-PS.
  • In 2006–2007 NBTY purchased PS-20 from Enzymotec and other suppliers; in 2007 Enzymotec contends an oral agreement extended exclusivity; by 2008 the relationship deteriorated and litigation commenced (July 1, 2008).
  • The court granted the amendment, granted partial summary judgment for NBTY on the Lanham Act standing, and denied Enzymotec’s sur-reply as moot.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether good cause exists to modify the scheduling order Enzymotec delayed discovery due to settlement efforts and new facts surfaced late. NBTY argued no good cause since February 2006 facts were known earlier. Yes; good cause shown to modify scheduling order.
Whether Enzymotec may amend under Rule 15(a) Amendment necessary to add Breach of Supply Agreement based on new discovery. Prejudice and undue delay unless allowed. Yes; amendment granted.
Lanham Act standing of Enzymotec Enzymotec has reasonable interest and basis to show injury due to competition. Enzymotec lacks direct competition or adequate causal basis. Granted partial summary judgment dismissing Lanham Act claim for lack of standing.
Whether a sur-reply should be filed Sur-reply needed to address new discovery arguments and damages theories. Sur-reply unnecessary. Denied as moot.

Key Cases Cited

  • Kassner v. 2nd Ave. Delicatessen, Inc., 496 F.3d 229 (2d Cir. 2007) (good cause for extending deadlines under Rule 16(b) and Rule 15(a) analysis)
  • Grochowski v. Phoenix Construction, 318 F.3d 80 (2d Cir. 2003) (Rule 16(b) good cause standard governs scheduling-order modification)
  • Foman v. Davis, 371 U.S. 178 (1962) (leave to amend freely absent undue prejudice or bad faith)
  • United States v. Continental Illinois Nat'l Bank & Trust Co., 889 F.2d 1248 (2d Cir. 1989) (prejudice and burden shifting in amendment disputes)
  • Famous Horse Inc. v. 5th Ave. Photo Inc., 624 F.3d 106 (2d Cir. 2010) (standing under Lanham Act depends on reasonable interest and basis; competition as indication)
Read the full case

Case Details

Case Name: Enzymotec Ltd. v. NBTY, INC.
Court Name: District Court, E.D. New York
Date Published: Dec 7, 2010
Citations: 754 F. Supp. 2d 527; 2010 WL 4959883; 2010 U.S. Dist. LEXIS 128962; 08-CV-2627 (ADS)(ETB)
Docket Number: 08-CV-2627 (ADS)(ETB)
Court Abbreviation: E.D.N.Y
Log In
    Enzymotec Ltd. v. NBTY, INC., 754 F. Supp. 2d 527